MONECO Advisors »

Denali Therapeutics shares owned by MONECO Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by MONECO Advisors from 13F filings

Historical chart of MONECO Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by MONECO Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by MONECO Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $265k 9.1k 29.13
2024-06-30 $202k 8.7k 23.22

More positions owned by MONECO Advisors

Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr S&p 100 Etf (OEF)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Microsoft Corporation (MSFT)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for MONECO Advisors

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
BlackRock
Vanguard Group
Capital Research Global Investors
Crestline Management
State Street Corporation
Baker Bros. Advisors
Geode Capital Management
T. Rowe Price Associates
Alliancebernstein
Marshall Wace
Dimensional Fund Advisors
Bank of New York Mellon
Principal Financial Group

View all funds holding Denali Therapeutics